Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Zymtronix
AddedFeb 16, 2024
UpdatedJun 18, 2026
Zymtronix

Zymtronix

Seed

US-based Zymtronix revolutionizes Green Chemistry with its innovative enzyme integration platform.

HQ
Ithaca, NY, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded in Ithaca, United States, Zymtronix is dedicated to revolutionizing Green Chemistry through its innovative enzyme integration platform. The company's core mission is to enhance the efficiency and sustainability of biocatalysis, thereby driving the next wave of improvements in this field. Zymtronix offers a multi-scale platform technology that optimizes the use of enzymes, catering primarily to industries focused on sustainable chemical processes and biological products.

Notable figures affiliated with Zymtronix include Thomas Videbæk, who recently joined the Board of Directors, and Stéphane Corgié, PhD. The company has also formed a significant partnership with Ginkgo Bioworks, underscoring its collaborative approach to innovation. Key achievements include the development of their groundbreaking enzyme platform and participation in high-profile events such as the Hello Tomorrow Global Summit. Zymtronix's impact lies in its potential to transform industrial applications of enzymes, promoting greener and more efficient chemical processes.

Zymtronix - Similar Companies

Zymochem logo

Zymochem

zymochem.com

Cascade Biocatalysts logo

Cascade Biocatalysts

SyntheZyme logo

SyntheZyme

Evozym Biologics logo

Evozym Biologics

Solugen logo

Solugen

solugen.com

Tethys Research logo

Tethys Research

tethysresearch.com

Novozymes logo

Novozymes

novozymes.com

Elemental Enzymes logo

Elemental Enzymes

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Zymeron logo

Zymeron

zymeron.com

GreenLab logo

GreenLab

greenlab.com

Enzymatics logo

Enzymatics

Synata Bio logo

Synata Bio

synatabio.com

eXoZymes logo

eXoZymes

invizyne.com

Zymosense logo

Zymosense

zymosense.com

Zymtronix - Quick Facts

Who are Zymtronix's competitors?

Companies similar to Zymtronix include Zymochem, Cascade Biocatalysts, SyntheZyme and Evozym Biologics.

When was Zymtronix founded?

Zymtronix was founded in 2013.

Where is Zymtronix's headquarters located?

Zymtronix's headquarters is located in Ithaca, NY, US.

When was Zymtronix's last funding round?

Zymtronix's most recent funding round was for $2M (USD) in December 2021.

How much has Zymtronix raised to-date?

As of Dec 1, 2021, Zymtronix has raised a total of $4.9M (USD).

How many employees does Zymtronix have?

Zymtronix has 24 employees as of Feb 5, 2024.

Zymtronix - Classification

Ownership
  • Venture Capital
Technology
  • Enzyme Engineering
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biocatalysis
  • Green Chemistry
Tags
  • Biotech
  • Cleantech
  • Technology
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified